All NIH Funding Opportunities and Notices

• Revised Guidance on Protecting Life in Global Health Assistance
  (NOT-OD-19-079)
  National Institutes of Health
  

• Notice of Amendment of RFA-AR-19-028 "HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional)
  (NOT-AR-19-036)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Office of Behavioral and Social Science Research
  

• Notice of NCCIH's Participation in PA-19-065, "Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)"
  (NOT-AT-19-022)
  National Center for Complementary and Integrative Health
  

• Notice of Correction to RFA-CA-19-008 "The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed)"
  (NOT-CA-19-026)
  National Cancer Institute
  

• Notice of Removal of Matching Requirement Instructions for RFA-EB-18-003 "HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)"
  (NOT-EB-19-003)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice to Change to Allowable Application Types in Response to PAR-17-340 "Collaborative Program Grant for Multidisciplinary Teams (RM1)"
  (NOT-GM-19-022)
  National Institute of General Medical Sciences
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)
  (NOT-HL-19-682)
  National Heart, Lung, and Blood Institute
  

• Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed)
  (RFA-CA-19-044)
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program (U18)
  (RFA-FD-19-004)
  Food and Drug Administration
  Application Receipt Date(s): April 30, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  

• Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)
  (RFA-FD-19-006)
  Food and Drug Administration
  Application Receipt Date(s): May 31, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  

Past Tables of Contents

• (none)

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892